AbbVie Receives U.S. FDA Approval of VIEKIRA PAK? (Ombitasvir/Paritaprevir/Ritonavir Tablets; Dasabuvir Tablets) for the Treatment of Chronic Genotype 1 Hepatitis C

Press/Media: Press / Media

PeriodDec 20 2014

Media coverage

1

Media coverage

  • TitleAbbVie Receives U.S. FDA Approval of VIEKIRA PAK? (Ombitasvir/Paritaprevir/Ritonavir Tablets; Dasabuvir Tablets) for the Treatment of Chronic Genotype 1 Hepatitis C
    Media name/outletPharmacy Choice
    CountryUnited States
    Date12/20/14
    PersonsFred Poordad